Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Intracranial Aneurysm Market, by End-use
1.4.2 North America Intracranial Aneurysm Market, by Type
1.4.3 North America Intracranial Aneurysm Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Intracranial Aneurysm Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Clinics Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Intracranial Aneurysm Market by Type
5.1 North America Endovascular Coiling Market by Country
5.2 North America Flow Diverters Market by Country
5.3 North America Surgical Clipping Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Intracranial Aneurysm Market by Country
6.1 US Intracranial Aneurysm Market
6.1.1 US Intracranial Aneurysm Market by End-use
6.1.2 US Intracranial Aneurysm Market by Type
6.2 Canada Intracranial Aneurysm Market
6.2.1 Canada Intracranial Aneurysm Market by End-use
6.2.2 Canada Intracranial Aneurysm Market by Type
6.3 Mexico Intracranial Aneurysm Market
6.3.1 Mexico Intracranial Aneurysm Market by End-use
6.3.2 Mexico Intracranial Aneurysm Market by Type
6.4 Rest of North America Intracranial Aneurysm Market
6.4.1 Rest of North America Intracranial Aneurysm Market by End-use
6.4.2 Rest of North America Intracranial Aneurysm Market by Type
Chapter 7. Company Profiles
7.1 MicroVention, Inc. (Terumo Corporation)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and Approvals:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 MicroPort Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental & Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Integra LifeSciences Holdings Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Delta Surgical
7.8.1 Company Overview
7.9 Penumbra, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
Unique Offerings 